Today: 8 June 2026
Browse Category

NASDAQ:LIMN 3 February 2026

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma shares jumped 29.4% to $0.74 in premarket trading Tuesday after surging 64.6% to $0.94 in Monday’s after-hours session. The stock remains below the $1 minimum required for Nasdaq listing, with the company facing a July 14, 2026 deadline to regain compliance. Liminatus disclosed it received a Nasdaq deficiency notice in January. Market cap stood near $15.5 million.
3 February 2026
·

Stock Market Today

  • Wall Street Rises as Nasdaq Rebounds, Intel Leads Chip Rally; Oil Prices Ease
    June 8, 2026, 1:44 PM EDT. Wall Street advanced with the Nasdaq rebounding after recent losses. Intel spearheaded a rally in semiconductor stocks, boosting investor sentiment. Oil prices eased amid signs of de-escalation between Iran and Israel, lowering geopolitical risk premiums. Meanwhile, SpaceX is generating buzz over a potential initial public offering (IPO), and efforts continue around a possible pardon for Sam Bankman-Fried (SBF), former CEO of FTX. These developments influenced market dynamics across sectors, reflecting cautious optimism amid ongoing geopolitical and regulatory developments.

Latest articles

ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

8 June 2026
ASML’s market value soared to a European record of $691.8 billion as analysts raised estimates for its EUV machine output, driving U.S. shares up 7.1% after JPMorgan and Morgan Stanley hiked price targets, with investors betting on ASML’s control of critical chipmaking tools amid surging AI demand and factory expansions planned for 2026.
Meta $145 Billion AI Push Faces Snag With Wall Street

Meta $145 Billion AI Push Faces Snag With Wall Street

8 June 2026
Meta shares fell 0.8% to $587.97 Monday after reports the company may sell tens of billions in new stock to fund AI infrastructure, raising investor concerns about dilution as capital spending soars and AI financing shifts from earnings to equity markets; Meta has not hired banks and may still consider other financing options.
Palantir’s $200 Target Meets Doubts on AI Growth

Palantir’s $200 Target Meets Doubts on AI Growth

8 June 2026
Palantir shares steadied at $135.73 after a volatile week, as investors weighed 85% Q1 revenue growth and a raised 2026 forecast against a steep 96x forward earnings valuation, with analysts warning that any slowdown in U.S. commercial or government revenue, or a shift in AI sentiment, could sharply impact the stock’s high multiple.
Go toTop